Erratum to: Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients

被引：0
|
作者：
Takuya Wakamiya
Tatsunori Hokosaki
Shin-ichi Tsujimoto
Keisuke Kadota
Yusuke Nakano
Shigeo Watanabe
Mari Iwamoto
Masakatsu Yanagimachi
Shuichi Ito
机构：
[1] Yokohama City University School of Medicine,Department of Pediatrics
来源：
Molecular Diagnosis & Therapy | 2016年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 501
相关论文
共 50 条
  • [21] Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey
    Ahmet Kocael
    Allison Pınar Eronat
    Mete Bora Tüzüner
    Ahmet Ekmekçi
    Ahmet Lütfullah Orhan
    İbrahim İkizceli
    Hülya Yılmaz-Aydoğan
    Oğuz Öztürk
    [J]. Molecular Biology Reports, 2019, 46 : 1825 - 1833
  • [22] Warfarin Pharmacogenetics: Polymorphisms of the CYP2C9, CYP4F2, and VKORC1 Loci in a Genetically Admixed Omani Population
    Pathare, Anil V.
    Al Zadjali, Shoaib
    Misquith, Rhea
    Alkindi, Salam S.
    Panjwani, Vinodh
    Lapoumeroulie, Claudine
    Pravin, Sahaya
    Paldi, Andras
    Krishnamoorthy, Rajagopal
    [J]. HUMAN BIOLOGY, 2012, 84 (01) : 67 - 77
  • [23] Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population
    Ozer, Mahmut
    Demirci, Yeliz
    Hizel, Candan
    Sarikaya, Sabit
    Karalti, Iskender
    Kaspar, Cigdem
    Alpan, Serdar
    Genc, Ece
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (03) : 209 - 214
  • [24] The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population
    Taskin, Birce Dilge
    Kula, Serdar
    Ergun, Mehmet Ali
    Altun, Demet
    Olgunturk, Rana
    Tunaoglu, Fatma Sedef
    Oguz, Ayse Deniz
    Gursel, Turkiz
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (10): : 791 - 796
  • [25] Effect of CYP2C9, VKORC1, CYP4F2, and GGCX gene variants and patient characteristics on acenocoumarol maintenance dose: Proposal for a dosing algorithm for Moroccan patients
    Elkhazraji, Abdelhak
    Bouaiti, El Arbi
    Boulahyaoui, Hassan
    Nahmtchougli, Christiana Philippa
    Zahid, Hafid
    Bensaid, Mounia
    Ibrahimi, Azeddine
    Messaoudi, Nezha
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2018, 12 (02): : 68 - 76
  • [26] Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population
    Dhakchinamoorthi Krishna Kumar
    Deepak Gopal Shewade
    Marie-Anne Loriot
    Philippe Beaune
    Jayaraman Balachander
    B. V. Sai Chandran
    Chandrasekaran Adithan
    [J]. European Journal of Clinical Pharmacology, 2014, 70 : 47 - 56
  • [27] Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population
    Kumar, Dhakchinamoorthi Krishna
    Shewade, Deepak Gopal
    Loriot, Marie-Anne
    Beaune, Philippe
    Balachander, Jayaraman
    Chandran, B. V. Sai
    Adithan, Chandrasekaran
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (01) : 47 - 56
  • [28] The Frequency of CYP2C9, VKORC1, and CYP4F2 Polymorphisms in Russian Patients With High Thrombotic Risk
    Ivashchenko, Dmitriy
    Rusin, Ilya
    Sychev, Dmitriy
    Grachev, Audrey
    [J]. MEDICINA-LITHUANIA, 2013, 49 (12): : 517 - 521
  • [29] Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study
    Sridharan, Kannan
    Al Banna, Rashed
    Malalla, Zainab
    Husain, Aysha
    Sater, Mai
    Jassim, Ghufran
    Otoom, Sameer
    [J]. PHARMACOLOGICAL REPORTS, 2021, 73 (05) : 1405 - 1417
  • [30] A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 640 - 648
12345